A cosmetics manufacturer contract is the legal framework that defines the rights, obligations, ownership, and remedies between a brand and its contract manufacturer.
That sounds simple.
In practice, the contract a founder signs typically looks like a generic template the manufacturer uses with all clients. The clauses that protect the manufacturer are clearly written. The clauses that protect the brand are often missing, vague, or written to favor the manufacturer.
That is rarely deliberate.
It is just how default templates work.
Most contracts in this industry are not drafted with the founder’s protection as the primary goal, and most founders do not know what to ask for. The result: contracts where formula ownership is unclear, exclusivity is undefined, and termination favors the manufacturer.
After 30 years in the hair and beauty sector, most recently in private label cosmetics, with a network of 14+ manufacturers across Europe, Turkey, China, and the US, I have reviewed many contracts and watched what happens when key clauses are missing.
This article covers what should be in your contract, why each clause matters, and what to discuss with an attorney.
Important disclaimer: I am not a lawyer. This article is practical guidance from industry experience, not legal advice. Every contract should be reviewed by a qualified attorney before signing.
Many first-time founders skip the contract step. They proceed on the basis of an accepted quote, a few emails, and a verbal agreement. The manufacturer is reputable, the relationship is friendly, and writing up a formal agreement feels unnecessary.
This is the most expensive shortcut a founder can take.
Without a contract, every disputed point becomes a negotiation under pressure.
When the first batch arrives with quality issues, when the manufacturer raises prices unexpectedly, when you want to take your formula to a different facility, when a competitor launches a suspiciously similar product, you have no agreed framework to reference.
Verbal agreements and email exchanges are evidence in some jurisdictions, but they are weak evidence compared to a signed contract.
The cost of pursuing remedies through verbal agreements is high enough that most disputes simply get absorbed by the brand.
Scaling is where the gap shows itself. Founders who cannot move their formula find out at the worst possible moment: when volume needs a second facility, when a distributor asks for a market-specific variant, or when a buyer asks what the company actually owns.
Most of those challenges trace back to contract gaps that could have been closed at the relationship’s start.
A well-structured cosmetics manufacturer contract does four things:
It defines who owns what (formula, IP, packaging artwork, label design, regulatory documentation).
It sets quality and compliance standards in writing, with consequences for breaches.
It establishes commercial terms (pricing, MOQ, lead times, payment terms, change control) clearly.
It provides exit pathways (termination, transition assistance, what happens to inventory and formula access).
Each of these areas is covered in the sections below. The contract does not need to be 50 pages long to cover them well. A 10-12 page contract that addresses each clearly is far more protective than a 30-page template that buries key terms or leaves them vague.
Of all contract dimensions, IP and formula ownership is the one most likely to cause expensive problems years later if it is not handled correctly at signing.
The formula is the product itself.
It is the basis of every claim and the reason customers buy and re-buy.
If you do not own the formula, you are renting your own product from your manufacturer. Practical consequences:
The manufacturer can raise prices and you have a limited negotiating position because moving production requires re-developing the formula elsewhere.
The manufacturer can discontinue your product line and you have no path forward without restarting product development.
The manufacturer can sell the same or substantially similar formula to another brand, including your competitor.
You cannot scale production by adding a second manufacturing partner without re-development.
Selling or licensing your brand becomes harder because IP value is reduced when the formula is not yours.
Owning a factory is the exception in this industry. Outside the large groups that run their own plants, brands produce through third-party manufacturers.
Which means formula ownership is settled by what the contract says, not by who makes the product.
If your contract is silent on formula ownership, default outcomes vary by jurisdiction and case law, but the typical default favors whoever invested in development.
For a manufacturer providing a "free" or low-cost formulation as part of the production package, that default favor goes to them.
Different production paths create different ownership starting points.
Stock formula (white label). The manufacturer provides a pre-existing formula they offer to multiple clients. You are buying production capacity using that formula with your branding, without owning the formula itself. This is the standard arrangement and reasonable for early-stage low-MOQ launches. The contract should still address what happens if you want to take production elsewhere later.
Base-derived formula (private label). The manufacturer modifies an existing base formula to your specifications. Ownership of the modifications is the negotiable point. Best practice: the manufacturer retains rights to the base, you own the specific customizations, and a confidentiality clause prevents the manufacturer from selling the modified version to other clients for a defined period.
Custom formula (full custom private label). The manufacturer develops a new formula based on your brief. You should own this formula outright, with the contract explicitly transferring all IP rights to you. If the manufacturer insists on retaining ownership, the development cost should reflect that (significantly lower) and you should understand you are creating a long-term dependency.
Regardless of the production path, your contract should explicitly address:
Formula ownership at contract signing. Who owns the formula at the moment of signing? Stock formulas: the manufacturer. Custom formulas: ideally you, with all IP transferred. Base-derived formulas: a hybrid arrangement specified clearly.
Improvements and modifications during the relationship. If the formula is improved over time (pH adjustments, ingredient swaps for supply reasons, performance refinement), who owns the improved version? Best practice: improvements made specifically for your product belong to you; general improvements to the manufacturer’s base formula remain theirs.
Trade secret and confidentiality. The contract should require the manufacturer to treat your formula, ingredient sources, packaging specifications, and supplier list as confidential information, with defined remedies for breach.
Trademarks, brand names, and visual IP. These should always remain 100% yours, with the manufacturer prohibited from using your brand name, logo, or product names in their own marketing, factory tours, or sales materials without written permission. The trademark protection guide for cosmetic brands covers brand-side IP registration.
Non-compete and exclusivity. Whether the manufacturer can produce identical or substantially similar products for other clients, and under what conditions. This is its own complex clause, covered next.
The single most expensive contract gap I see in this industry is unclear formula ownership. Brands sign contracts believing they own their formula, then discover years later that the manufacturer can sell the same formula to a competitor or refuse to release it to another facility. Closing this gap at signing costs nothing. Closing it later costs years of brand value.
Ownership is one dimension of the IP question.
The other dimension, often confused with ownership but legally distinct, is exclusivity.
Exclusivity is a separate question from ownership.
Even if you own the formula, you may want exclusivity around the manufacturer’s commitment to not produce identical or similar products for other brands.
Most contract content online does not say this clearly: whether exclusivity is available at all depends entirely on the production path, and the honest answer varies.
White label: exclusivity is structurally impossible. White label exists because the manufacturer is selling the same ready-made formula to many clients simultaneously. That is the entire value proposition. Asking a white label manufacturer for formula exclusivity means asking them to abandon the business model that makes white label affordable. If a manufacturer offers you exclusivity on a white label product, either the price reflects that (much higher than standard) or the offer is not what it appears.
The trade-off is known and accepted when choosing white label.
That is the documented cost of the faster launch and the lower MOQ: no formula exclusivity.
Full custom private label: exclusivity is possible, with proportional cost. When the manufacturer develops a new formula from scratch based on your brief, asking for exclusivity is reasonable. But you must also accept the cost structure this creates.
A custom formula developed for you with exclusivity means the manufacturer is treating your project as single-client R&D. All development costs, stability testing, regulatory documentation, and compliance files must be charged to you, not spread across multiple clients. This typically translates to 15,000-30,000 EUR/USD in development costs alone, plus the regulatory documentation work handled by either an in-house or external Responsible Person. (All cost figures in this article are indicative estimates that vary by manufacturer, region, and project scope.)
You can ask for exclusivity on a custom formula.
You should expect to pay for the exclusivity through the full R&D cost structure.
Hybrid approach: exclusivity is negotiable, with three realistic compromise paths. The hybrid approach (base-derived private label, the most common path) is where exclusivity becomes a real negotiation because the starting point is a shared base formula modified for your product.
The manufacturer has an incentive to continue using the base formula with other clients. You have an incentive to protect your specific formulation.
The conversation usually lands in one of three compromise zones:
First, volume-based full exclusivity: the manufacturer agrees to lock the modified formula for you, but only if your volume commitments are significant enough to justify the opportunity cost. If you are ordering 50,000+ units per year, this math often works. If you are ordering 2,000 units per year, the manufacturer will often decline. The calculation is economic, not personal.
Second, variant-specific exclusivity: the manufacturer agrees to give you exclusivity on a specific variant of the formula (a particular fragrance, color, concentration, or actives profile) while keeping the underlying base available for other clients. You get meaningful differentiation in-market; the manufacturer keeps their broader commercial flexibility.
Third, geographic or channel exclusivity: the manufacturer gives you exclusivity within a specific territory (your home country, a specific continent) or a specific sales channel (only online, only salons), while retaining rights to sell to other clients outside your defined scope. This works particularly well for brands with clear geographic or channel focus and is easier to agree than full global exclusivity.
The practical framework:
For white label: do not ask for exclusivity. Focus contract protection on confidentiality of the specific product choices you made (colors, fragrances, combinations), not the formula itself.
For base-derived private label: propose one of the three compromise paths above, starting with the path most aligned with your commercial reality. If you have volume, lead with volume-based exclusivity. If you are geographically focused, lead with territorial exclusivity.
For full custom: ask for full exclusivity, but budget for the development costs it implies.
For most early-stage brands, no exclusivity with strong confidentiality is still the most economically sensible starting point. Exclusivity becomes worth the cost when volume and brand value justify it.
What gets produced is only half of what the contract should cover.
It should specify the quality standards, compliance frameworks, and operational expectations that govern how it gets produced.
The clauses that turn quality from a hope into an obligation:
Some manufacturers will resist this; serious manufacturers accept it as standard.
This is one of the contract sections most often left ambiguous, and one of the most expensive when problems arise.
The contract should explicitly assign:
Once production starts, things change. Ingredient suppliers go out of business, raw material costs spike, or the manufacturer wants to substitute one preservative for another. Without change control rules, these changes can happen silently, and you discover them only when a customer notices the product feels different.
The contract should require:
The commercial terms section is where most founder attention goes during negotiation, often at the expense of the protective clauses above. Both matter.
The clauses that should be explicitly written:
Most manufacturer contracts include liability caps, often limiting the manufacturer’s total liability to the value of the order in question. From the brand’s perspective, this is often inadequate.
The clauses to negotiate:
One reality most contract advice online skips over: contract flexibility depends heavily on the manufacturer’s size relative to yours.
Large manufacturers almost always have standard contract templates drafted by their legal teams, and they are structurally resistant to modifying them for smaller clients. The reason is cost structure. Their contracts flow through in-house or external legal offices with associated hourly rates. Any meaningful amendment triggers legal review costs the manufacturer does not want to absorb for a client who is not producing large volumes.
The practical implications:
If you are a small-to-mid brand approaching a large manufacturer, expect the contract template to arrive mostly non-negotiable on structural terms. You can usually negotiate commercial terms (pricing, MOQ, lead times, payment schedule) but IP clauses, exclusivity frameworks, termination structures, and dispute resolution venues are often fixed. The manufacturer’s answer to significant redline requests will often be "we cannot modify that clause for your volume level".
That is how scale economics work in the industry, not a red flag.
If you are a mid-to-large brand approaching a similar-size manufacturer, negotiation becomes realistic. Both sides have legal resources, both sides have reasons to protect their positions, and the contract process often takes 4-8 weeks of back-and-forth between the two legal teams. At that scale, the brand founder is often not even directly involved; the legal counsel on each side negotiates the terms.
If you are a small brand approaching a small-to-mid manufacturer, contract flexibility is highest. Smaller manufacturers typically do not have expensive legal infrastructure, and they negotiate contracts with the brand founder directly. Changes can happen quickly, terms can be genuinely customized, and the contract often reflects a more balanced relationship.
The implication for founders: match your ambition on contract customization to the scale of the manufacturer you are approaching. Pushing for extensive contract customization with a large manufacturer whose volume you do not justify will often fail, not because the terms are unreasonable but because the administrative cost does not fit their model. Saving that negotiation energy for a manufacturer whose scale matches yours usually produces a better result.
This is the section most contracts handle poorly from the brand’s perspective. The defaults often favor the manufacturer (they can terminate easily, you cannot; you owe them inventory costs at termination, they keep your formula).
The clauses to write explicitly:
When the brand and the manufacturer are in different countries, the contract needs to address dimensions that single-jurisdiction contracts do not.
The practical implication: cross-border contracts benefit from explicit discussion of expectations beyond the written terms. If you and your manufacturer interpret the contract differently in spirit, even a well-drafted agreement will create recurring friction.
The cosmetics manufacturer red flags guide covers the warning signs to recognize during contract negotiation, and the exit playbook for situations where the relationship breaks down.
The contract is the floor, not the ceiling, of the relationship.
A well-written contract protects you when the relationship breaks down. It does not, by itself, create a relationship that produces good results.
One observation most contract guides for founders leave out:
Everything covered in the sections above is written from the brand’s perspective, with the goal of protecting the founder. That is appropriate, and I stand behind every clause recommended. But there is a symmetry to how contracts actually work that founders should understand before entering negotiation.
The more protective clauses a brand asks for, the more protective clauses the manufacturer will ask for in return. This is how balanced agreements get reached.
If you ask for tight quality specifications with defined penalties for breaches, the manufacturer will ask for tight payment terms with defined penalties for delays. If you ask for strict change control preventing silent substitutions, the manufacturer will ask for strict artwork approval preventing late design changes that disrupt production. If you ask for formula ownership with full transition assistance at termination, the manufacturer will ask for stronger commercial commitments (minimum annual volumes, longer contract terms).
From years of watching contracts get negotiated and then executed: many of the issues that come up in practice (production delays, quality disputes, payment disputes) are actually caused by the brand side more often than founders want to acknowledge. Late artwork approvals, delayed payments, last-minute specification changes, missed purchase order timings. Manufacturers have seen this pattern many times and they build their contract protections against it.
The practical implication: a contract negotiated with maximum protection for the brand will usually result in a contract with maximum protection for the manufacturer too. Both sides lose flexibility. Both sides lose the ability to handle the inevitable small deviations that happen in real production relationships.
This is an argument for measured contract protection, not against contract protection: cover the real risks without over-engineering every dimension. The contract should be solid on the clauses that matter most (formula ownership, quality standards, termination, exit) and allow reasonable flexibility on operational dimensions that benefit both sides when they remain negotiable.
A contract cannot make a manufacturer care about your launch. It cannot make them prioritize your urgent reorder when they have a larger client’s order ahead of yours. It cannot make them flag a small quality concern that fits within spec but might affect customer experience. It cannot make them suggest a better packaging option that costs less.
Those things come from relationship quality, not contract clauses.
The best client-manufacturer relationships I have seen across 30 years all share a pattern: the contract is solid, comprehensive, and protective of both sides, AND the day-to-day operation runs on trust, mutual respect, and informal communication that goes well beyond the contract requirements.
The contract sits in a drawer, referenced when needed, providing the safety net that allows the relationship to operate informally for everything else.
When manufacturers know the contract is fair to both sides, they relax. They share information they would not share if they felt the brand was looking for opportunities to extract more from them. They flag concerns early. They suggest improvements. They become a partner rather than just a supplier.
The clients I have worked with longest, the ones whose brands have grown over years, all have one thing in common: their contracts are solid and rarely opened. The relationship runs on trust, on flagging things early, on giving the manufacturer the same respect they expect to receive. The contract is there, but it is not what makes the relationship work.
The contract creates the conditions for that.
Most contract disputes I have seen could have been resolved through direct conversation if they had been raised early. By the time a brand starts threatening contract enforcement, the relationship is usually already broken.
Escalation to formal contract enforcement is appropriate for:
For everything else, the conversation comes first. The contract is the backstop, not the first move.
Yes, always, regardless of the relationship’s size or apparent friendliness. A written contract is a sign that both sides take the relationship seriously enough to define terms in advance, not a sign of distrust. Without a written contract, every dispute becomes a negotiation under pressure. The cost of a properly drafted contract (2,000-5,000 EUR for legal review) is dramatically lower than the cost of resolving even one significant dispute without one. Many manufacturers will offer a standard contract template; you should still have it reviewed by your own attorney before signing, and be prepared to negotiate amendments. Manufacturers who refuse contract amendments or push for verbal agreements only are showing a red flag worth taking seriously.
It depends on the production path. For stock formulas (white label), the manufacturer owns the formula and you are buying production access. For base-derived formulas (private label), best practice is hybrid: the manufacturer retains rights to the base, you own the specific customizations made for your product. For fully custom formulas you commissioned, you should own the formula outright, with all IP transferred to you. The contract should explicitly specify which scenario applies and what ownership transfers happen at signing. Without explicit specification, default rules (which vary by jurisdiction) typically favor whoever invested most in development, which often means the manufacturer.
An exclusivity clause restricts the manufacturer from producing identical or substantially similar products for other clients. It is separate from formula ownership; you can own a formula without exclusivity, and you can have exclusivity without owning the formula. Exclusivity has a cost: manufacturers giving exclusivity typically require higher MOQ commitments, higher unit pricing, or upfront fees. For most early-stage brands, no exclusivity with strong confidentiality protections is the more economically sensible choice. Exclusivity becomes worth the cost when sales volume and brand value are high enough to justify the price premium and to make the manufacturer’s foregone alternative business meaningful.
Budget 2,000-5,000 EUR for a standard contract review by an attorney with experience in cosmetics manufacturing or supply chain agreements. The lower end of the range applies to relatively simple white label agreements with template contracts; the higher end applies to custom formulation agreements with significant IP and exclusivity provisions. This investment is one of the highest-ROI expenditures in your launch budget. A contract attorney will identify clauses that founders without legal training typically miss, including liability allocation, warranty periods, change control, termination assistance, and dispute resolution venue. Some attorneys offer fixed-fee contract review packages for cosmetics startups; ask in advance about scope and pricing structure.
The remedies depend on what the contract specifies and the nature of the breach. For quality breaches: typical remedies include reproduction at the manufacturer’s cost, partial or full refund, and credit toward future orders. For confidentiality breaches, monetary damages and injunctive relief stop the unauthorized use. For delivery breaches, the remedies are late delivery penalties, the right to source temporarily from alternative manufacturers, and termination rights for repeated breaches. For payment breaches by the brand: late payment penalties and production hold rights for the manufacturer. The contract should specify the consequences for each type of breach in advance, rather than leaving them to be negotiated at the moment of dispute. Most disputes are best resolved through direct conversation before escalating to formal contract enforcement; the contract provides the framework that makes such conversations productive.
A manufacturing agreement focuses on the production relationship: the manufacturer produces a specified product to specified standards using specified materials. A supply agreement focuses on the commercial relationship: the supplier provides specified products at specified prices and quantities. In cosmetics, the line between the two is often blurred, and most contracts cover both dimensions. The terminology matters less than the substance: regardless of what the document is called, ensure it covers IP and formula ownership, quality and compliance standards, pricing and lead times, termination and exit pathways, and dispute resolution. A document that addresses all five areas comprehensively is what you need, whatever it is titled.
Yes, but the difficulty depends on what the contract specifies and what you own. If you own the formula and the contract includes transition assistance clauses, switching is simple: you provide the formula documentation to the new manufacturer and they reproduce it. If the manufacturer owns the formula or the contract is silent on transition assistance, switching may require rebuilding the formula: 3 to 5 months if it is rebuilt from the new manufacturer’s base, 6 to 12 months from scratch, and significant cost either way. This is one of the reasons formula ownership and exit clauses matter so much at signing: they determine your strategic flexibility years later when conditions change. The red flags guide covers the exit playbook for situations where the relationship needs to end.
Keep reading
Independent cosmetics consultant or manufacturer "free advice": what each actually covers, the structural limits of each, and how to decide which role you need at each phase. From 30 years in the industry, the honest framework.
An honest comparison of cosmetics manufacturing regions (EU, Turkey, Korea, China, and the US), covering quality, compliance, MOQ, pricing, and when each region is the right choice. From 30 years working across four continents.
What cosmetics quality control actually covers, which tests are standard at each production stage, and how the formal system interacts with the trust-based relationship that makes it work in practice.
